Clinical Research Directory
Browse clinical research sites, groups, and studies.
Novel Digital Application for Patients With Acute Leukemia
Sponsor: Massachusetts General Hospital
Summary
This research study is evaluating to examine the efficacy of a novel a self-administered digital application (DREAMLAND) for improving patients' long-term quality of life and psychological outcomes for patients with acute myeloid leukemia undergoing intensive chemotherapy.
Official title: Multi-Site Randomized Controlled Trial of a Novel Digital Application (DREAMLAND) to Improve Outcomes for Patients With Acute Myeloid Leukemia
Key Details
Gender
All
Age Range
18 Years - 120 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2024-10-21
Completion Date
2030-04-30
Last Updated
2025-11-10
Healthy Volunteers
No
Conditions
Interventions
DREAMLAND
Participants assigned to DREAMLAND will start using DREAMLAND during the first week of their hospitalization, with a suggested timeline of reviewing one module each week to complete the required modules by week 4 of their hospital stay.
VITAL WELLNESS
Participants assigned to VITAL WELLNESS will start using VITAL WELLNESS during the first week of their hospitalization, with a suggested timeline of reviewing one module each week to complete the required modules by week 4 of their hospital stay.
Locations (3)
Massachusetts General Hospital (MGH)
Boston, Massachusetts, United States
Duke University
Durham, North Carolina, United States
Fred Hutchinson Cancer Research Center (FHCRC)
Seattle, Washington, United States